collision energy) of metabolites were as follows
Throughout the intervention phase, participants were assessed every four weeks to monitor treatment effects and safety
It does not cause photosensitivity (unlike retinoids), does not thin the skin (unlike corticosteroids), and does not require a tolerance-building period
Muscle cramps during GLP-1 therapy are typically caused by indirect factors including electrolyte depletion (especially magnesium and potassium) from gastrointestinal side effects, dehydration from reduced fluid intake or vomiting/diarrhea, rapid weight loss with some lean mass reduction, and increased physical activity exceeding current conditioning levels
If you are breast-feeding or are planning to breast-feed, talk to your doctor before using or continuing to use this medicine. If you have been offered a GLP-1 medicine to treat your diabetes and are making a decision about whether to take it and how this will impact your breastfeeding journey, or if you have been taking one of these medicines whilst breastfeeding, you can contact the Breastfeeding Network Drugs in Breastmilk team to discuss this